Clinical Trial Update: Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the anti-parasitic SAR97276A in children with uncomplicated malaria was terminated. The update does not include efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• SAR97276A

Snippet

Sponsor: Sanofi | Conditions: Malaria | Phase 2 | Status: TERMINATED